Strides’ founder Arun Kumar is quitting as the generics firm’s chief executive to focus on overall corporate strategy and on the firm’s reborn injectables business which he sees as a hugely lucrative opportunity.
Kumar will stay on as Strides’ chairman. But replacing him as CEO and managing director will be R Ananthanarayanan –...




